Federal Requirements is the domain that changed the most in PTCB’s January 6, 2026 content outline update — jumping from 12.5% to 18.75% of the exam, the single largest weighting increase across all four domains. Out of 90 total questions (80 scored), roughly 15 to 17 will draw from this domain. It’s smaller than Medications, but it’s also the domain most likely to trip up candidates who studied an older outline, since the topic list itself shifted along with the percentage.
This guide walks through every official subtopic, with the real federal rules PTCB expects you to know — not just the topic labels.
Why This Domain Deserves Fresh Attention
If you used an older study guide or a hand-me-down set of notes, this is the domain where that will hurt you most. The percentage increase reflects genuine content changes, including expanded coverage of restricted drug programs and product serialization requirements that weren’t previously part of the outline. Don’t assume last year’s Federal Requirements notes are still complete — verify against the current 2026 outline before you trust any single source, including this one.
What the Federal Requirements Domain Covers
PTCB organizes this domain into six official subtopics:
| # | Subtopic | What It Tests |
|---|---|---|
| 2.1 | Federal requirements for storage, handling, and disposal of non-hazardous, hazardous, and pharmacological substances and wastes | RCRA hazardous waste rules, P-listed substances |
| 2.2 | Federal requirements for controlled substance prescriptions and DEA schedules | New, refill, and transfer rules by schedule |
| 2.3 | Federal requirements for receiving, storing, ordering, labeling, dispensing, returning, take-back programs, loss/theft, and destruction of controlled substances | Full lifecycle handling of scheduled drugs |
| 2.4 | Federal restricted drug programs and related processing requirements | Pseudoephedrine (CMEA), REMS |
| 2.5 | FDA requirements for medication recalls | Recall classes and pharmacy response steps |
| 2.6 | FDA product serialization, tracking, tracing, handling, and quarantining requirements | DSCSA |
PTCB flags 2.2 and 2.4 as higher-emphasis areas within this domain, so controlled substance prescription rules and restricted drug programs deserve extra study time.
Storage, Handling, and Disposal of Hazardous Substances (2.1)
Pharmacies handle three broad waste categories under federal rules:
- Non-hazardous pharmaceutical waste: most unused, non-controlled medications that don’t meet EPA hazardous criteria
- Hazardous waste: substances regulated under the Resource Conservation and Recovery Act (RCRA), including drugs on the P-list (acutely hazardous) and U-list (toxic commercial chemical products)
- Controlled substance waste: requires DEA-compliant destruction methods separate from standard hazardous waste disposal
Know that hazardous pharmaceutical waste cannot simply be poured down a drain or thrown in regular trash — it requires designated collection and a registered hazardous waste hauler or reverse distributor.
DEA Controlled Substance Prescription Rules and Schedules (2.2)
This is one of the two flagged high-emphasis subtopics, and it’s the single most testable chunk of the domain. Know the five schedules cold:
| Schedule | Abuse Potential | Medical Use | Refills | Examples |
|---|---|---|---|---|
| I | Highest | None accepted (federally) | Not prescribable | Heroin, LSD, MDMA |
| II | High | Yes | No refills — new written Rx each time (oral allowed only in emergencies) | Oxycodone, morphine, Adderall, fentanyl |
| III | Moderate | Yes | Up to 5 refills within 6 months | Tylenol with codeine, ketamine, testosterone |
| IV | Low | Yes | Up to 5 refills within 6 months | Xanax, Valium, Ambien, tramadol |
| V | Lowest | Yes | Refillable per state/prescriber authorization; some available OTC in limited states | Cough preparations with small amounts of codeine, Lyrica |
Key prescription-processing rules to memorize:
- New Schedule II prescriptions require a written (or state-approved electronic) prescription; verbal orders are allowed only in true emergencies and must be followed by a written prescription within a defined window.
- Schedule II transfers between pharmacies are generally not permitted, unlike III–V.
- Schedule III–V prescriptions can be transferred between pharmacies (with documentation) and refilled up to 5 times within 6 months of the original prescription date.
- A prescriber can issue multiple separate Schedule II prescriptions at one visit (covering up to a 90-day supply total), but each is a distinct prescription — not a refill.
Receiving, Storing, Dispensing, and Destroying Controlled Substances (2.3)
This subtopic covers the full lifecycle of a controlled substance once it enters the pharmacy:
- Receiving/ordering: Schedule II drugs require DEA Form 222 (or the electronic CSOS equivalent) for ordering; Schedule III–V can be ordered through normal wholesaler invoicing
- Storage: controlled substances must be kept in a securely locked cabinet or dispersed throughout regular stock in a way that deters theft, per DEA guidance
- Labeling and dispensing: standard prescription labeling rules apply, plus any schedule-specific warning labels
- Loss or theft: must be reported to the DEA using Form 106, in addition to any state-level reporting requirements
- Destruction: must go through a DEA-registered reverse distributor or an authorized collection/take-back program — pharmacy staff cannot simply discard controlled substances in regular waste
- Take-back programs: DEA-authorized drop boxes and periodic National Prescription Drug Take Back Day events allow patients to safely dispose of unused medications, including controlled substances
Restricted Drug Programs (2.4)
The second flagged high-emphasis subtopic. Two federal programs dominate this area:
Pseudoephedrine restrictions (Combat Methamphetamine Epidemic Act):
- Sold behind the counter, without a prescription, but with purchase limits
- Requires photo ID and a signed logbook entry at the time of sale
- Daily and 30-day purchase quantity limits apply per federal law
Risk Evaluation and Mitigation Strategies (REMS):
- FDA-required safety programs for medications with serious safety concerns that outweigh their benefits unless specific conditions are met
- Can include prescriber certification, patient enrollment, mandatory counseling, or restricted distribution through certified pharmacies
- Pharmacy technicians should recognize when a REMS-restricted medication requires additional verification steps before it can be dispensed
FDA Medication Recalls (2.5)
The FDA classifies drug recalls into three classes based on health risk severity:
- Class I: Reasonable probability of serious health consequences or death — the most urgent recall category
- Class II: May cause temporary or reversible health consequences, with limited probability of serious harm
- Class III: Unlikely to cause any adverse health consequences
Pharmacies typically respond to a recall notice by pulling the affected lot/NDC from stock, checking for it in dispensed prescription records to notify affected patients when required, and documenting the recall response per pharmacy policy.
FDA Product Serialization and Tracking (2.6)
This subtopic centers on the Drug Supply Chain Security Act (DSCSA), the federal law building an electronic, interoperable system to trace prescription drugs as they move through the supply chain. Key concepts:
- Each package of certain prescription drugs carries a unique product identifier (serial number) for track-and-trace purposes
- The goal is to identify and remove counterfeit, stolen, contaminated, or otherwise harmful drugs from the supply chain
- Pharmacies must be able to verify product identifiers and quarantine suspect or illegitimate product rather than dispense it
- Trading partners (manufacturers, wholesalers, dispensers) must be able to trace a product’s chain of ownership
How to Study This Domain Efficiently
- Master the DEA schedule table first. Nearly every 2.2 and 2.3 question hinges on knowing refill rules, prescription requirements, and transfer rules by schedule.
- Separate “what’s restricted” from “how it’s restricted.” Pseudoephedrine and REMS are both restricted-access programs, but the mechanism (purchase logs vs. certification/enrollment) is different — don’t blur them together.
- Learn recall classes by consequence, not by number. Tie Class I/II/III to the severity of harm rather than memorizing the numbers in isolation.
- Treat 2.1 and 2.3 as lifecycle questions. Think in terms of a controlled substance’s full journey — ordering, storage, dispensing, loss/theft, destruction — rather than isolated facts.
- Don’t skip DSCSA just because it feels abstract. It’s a newer emphasis in the 2026 outline and is more testable than candidates expect.
Key Takeaways
- Federal Requirements grew from 12.5% to 18.75% in the 2026 outline — the biggest single change to the exam, so don’t rely on older prep material.
- The domain has six official subtopics, with DEA controlled substance rules (2.2) and restricted drug programs (2.4) flagged as higher-emphasis.
- Schedule II drugs cannot be refilled; Schedules III–V can be refilled up to 5 times within 6 months.
- Controlled substance loss or theft must be reported to the DEA on Form 106; ordering Schedule II drugs requires DEA Form 222 or CSOS.
- DSCSA governs product serialization and track-and-trace requirements across the drug supply chain.
Frequently Asked Questions
Q: How many PTCE questions come from the Federal Requirements domain? A: At 18.75% of 90 total questions (80 scored), expect roughly 15 to 17 questions from this domain.
Q: Can a Schedule II prescription be refilled? A: No. Schedule II prescriptions require a new prescription every time — refills are not permitted under federal law.
Q: What form is used to report a theft or significant loss of controlled substances? A: DEA Form 106, in addition to any applicable state reporting requirements.
Q: What changed most in the 2026 Federal Requirements outline? A: The domain’s weighting jumped from 12.5% to 18.75%, and its topic list was expanded to include more detail on restricted drug programs (2.4) and FDA product serialization/DSCSA requirements (2.6).
Continue Your PTCE Prep
Practice what you just studied:
- Beginner Quiz 1 · Beginner Quiz 2 · Beginner Quiz 3
- Intermediate Quiz 1 · Intermediate Quiz 2
- Full-Length Mock Exam 1 · Full-Length Mock Exam 2
Study the other three PTCE domains:
- Medications Domain Study Guide
- Patient Safety and Quality Assurance Domain Study Guide
- Order Entry and Processing Domain Study Guide
Go further:
- Comprehensive PTCE Study Guide (All 4 Domains)
- Unlock the Premium Study Dashboard →